{"id":50912,"date":"2022-11-15T22:04:23","date_gmt":"2022-11-15T21:04:23","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/doximity-to-participate-in-a-fireside-chat-at-raymond-james-technology-investor-conference\/"},"modified":"2022-11-15T22:04:23","modified_gmt":"2022-11-15T21:04:23","slug":"doximity-to-participate-in-a-fireside-chat-at-raymond-james-technology-investor-conference","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/doximity-to-participate-in-a-fireside-chat-at-raymond-james-technology-investor-conference\/","title":{"rendered":"Doximity to Participate in a Fireside Chat at Raymond James Technology Investor Conference"},"content":{"rendered":"<div>\n<p>SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211;Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that Anna Bryson, CFO, will participate in a fireside chat at Raymond James Technology Investor Conference on Monday, December 5, 2022, at 10:20 a.m. Eastern Time\/7:20 a.m Pacific Time.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221115005441\/en\/1636970\/5\/dox-logotype-black-rgb_copy.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221115005441\/en\/1636970\/21\/dox-logotype-black-rgb_copy.jpg\"><\/a><\/p>\n<p>\n<b>About Doximity<\/b>\n<\/p>\n<p>\nFounded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The Company&#8217;s network members include over 80% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, and conduct virtual patient visits. Doximity&#8217;s mission is to help doctors be more productive so they can provide better care for their patients. For more information, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.doximity.com&amp;esheet=52969134&amp;newsitemid=20221115005441&amp;lan=en-US&amp;anchor=www.doximity.com&amp;index=1&amp;md5=5fa2e33f281c414b515e7129ac8234f0\" rel=\"nofollow noopener\" shape=\"rect\">www.doximity.com<\/a>.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>For investors:<\/b><br \/>Perry Gold<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;t&#111;&#x3a;&#105;&#x72;&#64;&#x64;o&#120;&#x69;&#109;&#x69;t&#x79;&#x2e;&#99;&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">&#x69;&#114;&#64;&#x64;&#111;x&#x69;&#109;i&#x74;&#121;&#46;&#x63;&#111;m<\/a>\n<\/p>\n<p>\n<b>For media:<\/b><br \/>Amanda Cox<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#x6c;&#x74;&#x6f;&#58;&#112;&#114;&#64;doxi&#x6d;&#x69;&#x74;&#x79;&#x2e;&#x63;&#111;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">pr&#64;doxim&#105;&#116;&#121;&#46;&#99;&#111;&#109;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211;Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that Anna Bryson, CFO, will participate in a fireside chat at Raymond James Technology Investor Conference on Monday, December 5, 2022, at 10:20 a.m. Eastern Time\/7:20 a.m Pacific Time. About Doximity Founded in 2010, Doximity is the leading digital &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/doximity-to-participate-in-a-fireside-chat-at-raymond-james-technology-investor-conference\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-50912","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Doximity to Participate in a Fireside Chat at Raymond James Technology Investor Conference - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/doximity-to-participate-in-a-fireside-chat-at-raymond-james-technology-investor-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Doximity to Participate in a Fireside Chat at Raymond James Technology Investor Conference - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211;Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that Anna Bryson, CFO, will participate in a fireside chat at Raymond James Technology Investor Conference on Monday, December 5, 2022, at 10:20 a.m. Eastern Time\/7:20 a.m Pacific Time. About Doximity Founded in 2010, Doximity is the leading digital ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/doximity-to-participate-in-a-fireside-chat-at-raymond-james-technology-investor-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-15T21:04:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221115005441\/en\/1636970\/21\/dox-logotype-black-rgb_copy.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/doximity-to-participate-in-a-fireside-chat-at-raymond-james-technology-investor-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/doximity-to-participate-in-a-fireside-chat-at-raymond-james-technology-investor-conference\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Doximity to Participate in a Fireside Chat at Raymond James Technology Investor Conference\",\"datePublished\":\"2022-11-15T21:04:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/doximity-to-participate-in-a-fireside-chat-at-raymond-james-technology-investor-conference\\\/\"},\"wordCount\":173,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/doximity-to-participate-in-a-fireside-chat-at-raymond-james-technology-investor-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221115005441\\\/en\\\/1636970\\\/21\\\/dox-logotype-black-rgb_copy.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/doximity-to-participate-in-a-fireside-chat-at-raymond-james-technology-investor-conference\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/doximity-to-participate-in-a-fireside-chat-at-raymond-james-technology-investor-conference\\\/\",\"name\":\"Doximity to Participate in a Fireside Chat at Raymond James Technology Investor Conference - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/doximity-to-participate-in-a-fireside-chat-at-raymond-james-technology-investor-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/doximity-to-participate-in-a-fireside-chat-at-raymond-james-technology-investor-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221115005441\\\/en\\\/1636970\\\/21\\\/dox-logotype-black-rgb_copy.jpg\",\"datePublished\":\"2022-11-15T21:04:23+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/doximity-to-participate-in-a-fireside-chat-at-raymond-james-technology-investor-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/doximity-to-participate-in-a-fireside-chat-at-raymond-james-technology-investor-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/doximity-to-participate-in-a-fireside-chat-at-raymond-james-technology-investor-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221115005441\\\/en\\\/1636970\\\/21\\\/dox-logotype-black-rgb_copy.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221115005441\\\/en\\\/1636970\\\/21\\\/dox-logotype-black-rgb_copy.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/doximity-to-participate-in-a-fireside-chat-at-raymond-james-technology-investor-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Doximity to Participate in a Fireside Chat at Raymond James Technology Investor Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Doximity to Participate in a Fireside Chat at Raymond James Technology Investor Conference - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/doximity-to-participate-in-a-fireside-chat-at-raymond-james-technology-investor-conference\/","og_locale":"en_US","og_type":"article","og_title":"Doximity to Participate in a Fireside Chat at Raymond James Technology Investor Conference - Pharma Trend","og_description":"SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211;Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that Anna Bryson, CFO, will participate in a fireside chat at Raymond James Technology Investor Conference on Monday, December 5, 2022, at 10:20 a.m. Eastern Time\/7:20 a.m Pacific Time. About Doximity Founded in 2010, Doximity is the leading digital ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/doximity-to-participate-in-a-fireside-chat-at-raymond-james-technology-investor-conference\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-15T21:04:23+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221115005441\/en\/1636970\/21\/dox-logotype-black-rgb_copy.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/doximity-to-participate-in-a-fireside-chat-at-raymond-james-technology-investor-conference\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/doximity-to-participate-in-a-fireside-chat-at-raymond-james-technology-investor-conference\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Doximity to Participate in a Fireside Chat at Raymond James Technology Investor Conference","datePublished":"2022-11-15T21:04:23+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/doximity-to-participate-in-a-fireside-chat-at-raymond-james-technology-investor-conference\/"},"wordCount":173,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/doximity-to-participate-in-a-fireside-chat-at-raymond-james-technology-investor-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221115005441\/en\/1636970\/21\/dox-logotype-black-rgb_copy.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/doximity-to-participate-in-a-fireside-chat-at-raymond-james-technology-investor-conference\/","url":"https:\/\/pharma-trend.com\/en\/doximity-to-participate-in-a-fireside-chat-at-raymond-james-technology-investor-conference\/","name":"Doximity to Participate in a Fireside Chat at Raymond James Technology Investor Conference - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/doximity-to-participate-in-a-fireside-chat-at-raymond-james-technology-investor-conference\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/doximity-to-participate-in-a-fireside-chat-at-raymond-james-technology-investor-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221115005441\/en\/1636970\/21\/dox-logotype-black-rgb_copy.jpg","datePublished":"2022-11-15T21:04:23+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/doximity-to-participate-in-a-fireside-chat-at-raymond-james-technology-investor-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/doximity-to-participate-in-a-fireside-chat-at-raymond-james-technology-investor-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/doximity-to-participate-in-a-fireside-chat-at-raymond-james-technology-investor-conference\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221115005441\/en\/1636970\/21\/dox-logotype-black-rgb_copy.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221115005441\/en\/1636970\/21\/dox-logotype-black-rgb_copy.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/doximity-to-participate-in-a-fireside-chat-at-raymond-james-technology-investor-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Doximity to Participate in a Fireside Chat at Raymond James Technology Investor Conference"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50912","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=50912"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50912\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=50912"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=50912"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=50912"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}